ProCE Banner Activity

Managing Adverse Events Associated With BTK Inhibitors

Slideset Download
In this downloadable slideset, John C. Byrd, MD, discusses strategies for managing treatment-related adverse effects with BTK inhibitors in patients with B-cell malignancies.

Released: June 05, 2019

Expiration: June 03, 2020

No longer available for credit.

Share

Faculty

John C. Byrd

John C. Byrd, MD

D. Warren Brown Chair of Leukemia Research
Professor of Medicine,
Medicinal Chemistry and Veterinary Biosciences
Director, Division of Hematology
Department of Medicine
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
Columbus, Ohio

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

John C. Byrd, MD

D. Warren Brown Chair of Leukemia Research
Professor of Medicine,
Medicinal Chemistry and Veterinary Biosciences
Director, Division of Hematology
Department of Medicine
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
Columbus, Ohio